FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Senji Okuno

Research Profile

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Anatomy

Physiology

Co-author Network

Publications

TOP 3
Eiji Ishimura; Yoshiki Nishizawa; Kyoko Norimine; Senji Okuno; Shigeichi Shoji; Naoki Tsuboniwa; Kenjiro Yamakawa; Tomoyuki Yamakawa; Shinya Fukumoto; Masaaki Inaba
Significant positive association between parathyroid hormone and fat mass and lean mass in chronic hemodialysis patients.
Katsuhito Mori; Senji Okuno; Shigeichi Shoji; Tetsuo Shoji; Kenjiro Yamakawa; Tomoyuki Yamakawa; Masanori Emoto; Yasuo Imanishi; Eiji Ishimura; Yoshinori Kakutani; Masaaki Inaba
Tumor necrosis factor-related apoptosis-inducing ligand as an independent predictor of mortality in hemodialysis patents.
Senji Okuno; S Shoji; N Tsuboniwa; K Yamakawa; Tomoyuki Yamakawa; Eiji Ishimura; K Mori; Yoshiki Nishizawa; K Norimine; Masaaki Inaba
Significant inverse relationship between serum undercarboxylated osteocalcin and glycemic control in maintenance hemodialysis patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Senji Okuno (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Eiji Ishimura; Yoshiki Nishizawa; Kyoko Norimine; Senji Okuno; Shigeichi Shoji; Naoki Tsuboniwa; Kenjiro Yamakawa; Tomoyuki Yamakawa; Shinya Fukumoto; Masaaki Inaba
Significant positive association between parathyroid hormone and fat mass and lean mass in chronic hemodialysis patients.
The Journal of clinical endocrinology and metabolism 2013;98(3):1264-70.
2013: Katsuhito Mori; Senji Okuno; Shigeichi Shoji; Tetsuo Shoji; Kenjiro Yamakawa; Tomoyuki Yamakawa; Masanori Emoto; Yasuo Imanishi; Eiji Ishimura; Yoshinori Kakutani; Masaaki Inaba
Tumor necrosis factor-related apoptosis-inducing ligand as an independent predictor of mortality in hemodialysis patents.
Cytokine 2013;61(3):912-6.
2013: Senji Okuno; S Shoji; N Tsuboniwa; K Yamakawa; Tomoyuki Yamakawa; Eiji Ishimura; K Mori; Yoshiki Nishizawa; K Norimine; Masaaki Inaba
Significant inverse relationship between serum undercarboxylated osteocalcin and glycemic control in maintenance hemodialysis patients.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2013;24(2):605-12.
2012: Maki Yoda; Yasuo Imanishi; Masaaki Inaba; Eiji Ishimura; Katsuhito Mori; Senji Okuno; Tetsuo Shoji; Shinsuke Yamada; Tomoyuki Yamakawa; Koichiro Yoda; Shigeichi Shoji
Poor muscle quality as a predictor of high mortality independent of diabetes in hemodialysis patients.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2012;66(4):266-70.
2011: Eiji Ishimura; Yoshiki Nishizawa; Senji Okuno; S Shoji; N Tsuboniwa; K Yamakawa; Tomoyuki Yamakawa; M Ichii; Masaaki Inaba
Effect of cinacalcet on bone mineral density of the radius in hemodialysis patients with secondary hyperparathyroidism.
Clinical nephrology 2011;76(4):259-65.
2011: M Kurajoh; Masaaki Inaba; Senji Okuno; H Nagayama; Shinsuke Yamada; Yasuo Imanishi; Eiji Ishimura; S Shoji; Tomoyuki Yamakawa; Yoshiki Nishizawa
Reduction of whole PTH/intact PTH ratio as a predictor of bone metabolism in cinacalcet treatment of hemodialysis patients with secondary hyperparathyroidism.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2011;22(3):923-30.
2011: Eiji Ishimura; Yoshiki Nishizawa; Senji Okuno; Shigeichi Shoji; Naoki Tsuboniwa; Tomoyuki Yamakawa; Masaaki Inaba
Relationship between fat mass and serum high-sensitivity C-reactive protein levels in prevalent hemodialysis patients.
Nephron. Clinical practice 2011;119(4):c283-8.
2010: Masaaki Inaba; M Kurajoh; Senji Okuno; Yasuo Imanishi; Shinsuke Yamada; Katsuhito Mori; Eiji Ishimura; Tomoyuki Yamakawa; Yoshiki Nishizawa
Poor muscle quality rather than reduced lean body mass is responsible for the lower serum creatinine level in hemodialysis patients with diabetes mellitus.
Clinical nephrology 2010;74(4):266-72.
2010: T Yamamoto; Kyoko Nagasue; Senji Okuno; Tomoyuki Yamakawa
The role of peritoneal lavage and the prognostic significance of mesothelial cell area in preventing encapsulating peritoneal sclerosis.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 2010;30(3):343-52.
2010: Tetsuo Shoji; Kiyoshi Maekawa; Masanori Emoto; Senji Okuno; Tomoyuki Yamakawa; Eiji Ishimura; Masaaki Inaba; Yoshiki Nishizawa
Arterial stiffness predicts cardiovascular death independent of arterial thickness in a cohort of hemodialysis patients.
Atherosclerosis 2010;210(1):145-9.
2010: Hidenori Koyama; Sanae Fukuda; Tetsuo Shoji; Masaaki Inaba; Yoshihiro Tsujimoto; Tsutomu Tabata; Senji Okuno; Tomoyuki Yamakawa; Shigeki Okada; Mikio Okamura; Hirohiko Kuratsune; Hisako Fujii; Yoshinobu Hirayama; Yasuyoshi Watanabe; Yoshiki Nishizawa
Fatigue is a predictor for cardiovascular outcomes in patients undergoing hemodialysis.
Clinical journal of the American Society of Nephrology : CJASN 2010;5(4):659-66.
2010: Mitsuru Ichii; Eiji Ishimura; Senji Okuno; Hidenori Chou; Yoko Kato; Naoki Tsuboniwa; Kyoko Nagasue; Kiyoshi Maekawa; Tomoyuki Yamakawa; Masaaki Inaba; Yoshiki Nishizawa
Decreases in parathyroid gland volume after cinacalcet treatment in hemodialysis patients with secondary hyperparathyroidism.
Nephron. Clinical practice 2010;115(3):c195-202.
2009: Yoshifumi Maeno; Masaaki Inaba; Senji Okuno; Kaori Kohno; Kiyoshi Maekawa; Tomoyuki Yamakawa; Eiji Ishimura; Yoshiki Nishizawa
Significant association of fracture of the lumbar spine with mortality in female hemodialysis patients: a prospective observational study.
Calcified tissue international 2009;85(4):310-6.
2009: Kaori Kohno; Masaaki Inaba; Senji Okuno; Yoshifumi Maeno; Kiyoshi Maekawa; Tomoyuki Yamakawa; Eiji Ishimura; Yoshiki Nishizawa
Association of reduction in bone mineral density with mortality in male hemodialysis patients.
Calcified tissue international 2009;84(3):180-5.
2009: Eiji Ishimura; Senji Okuno; K Kono; Y Fujino-Kato; Y Maeno; S Kagitani; N Tsuboniwa; Kyoko Nagasue; Kiyoshi Maekawa; Tomoyuki Yamakawa; Masaaki Inaba; Yoshiki Nishizawa
Glycemic control and survival of diabetic hemodialysis patients--importance of lower hemoglobin A1C levels.
Diabetes research and clinical practice 2009;83(3):320-6.
2008: Kiyoshi Maekawa; Tetsuo Shoji; Masanori Emoto; Senji Okuno; Tomoyuki Yamakawa; Eiji Ishimura; Masaaki Inaba; Yoshiki Nishizawa
Influence of atherosclerosis on the relationship between anaemia and mortality risk in haemodialysis patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008;23(7):2329-36.
2008: Kaori Shidara; Masaaki Inaba; Senji Okuno; Shinsuke Yamada; Yasuro Kumeda; Yasuo Imanishi; Tomoyuki Yamakawa; Eiji Ishimura; Yoshiki Nishizawa
Serum levels of TRAP5b, a new bone resorption marker unaffected by renal dysfunction, as a useful marker of cortical bone loss in hemodialysis patients.
Calcified tissue international 2008;82(4):278-87.
2008: Eiji Ishimura; Senji Okuno; Hiromichi Taniwaki; Akane Kizu; Takao Tsuchida; Atsushi Shioi; Tetsuo Shoji; Tsutomu Tabata; Masaaki Inaba; Yoshiki Nishizawa
Different risk factors for vascular calcification in end-stage renal disease between diabetics and nondiabetics: the respective importance of glycemic and phosphate control.
Kidney & blood pressure research 2008;31(1):10-5.
2007: Eiji Ishimura; Senji Okuno; Tomoyuki Yamakawa; Masaaki Inaba; Yoshiki Nishizawa
Serum magnesium concentration is a significant predictor of mortality in maintenance hemodialysis patients.
Magnesium research : official organ of the International Society for the Development of Research on Magnesium 2007;20(4):237-44.
2007: Eiji Ishimura; Senji Okuno; Kayoko Kitatani; T Tsuchida; Tomoyuki Yamakawa; Atsushi Shioi; Masaaki Inaba; Yoshiki Nishizawa
Significant association between the presence of peripheral vascular calcification and lower serum magnesium in hemodialysis patients.
Clinical nephrology 2007;68(4):222-7.
2007: Senji Okuno; Eiji Ishimura; Kayoko Kitatani; Yoko Fujino; Kaori Kohno; Yoshifumi Maeno; Kiyoshi Maekawa; Tomoyuki Yamakawa; Yasuo Imanishi; Masaaki Inaba; Yoshiki Nishizawa
Presence of abdominal aortic calcification is significantly associated with all-cause and cardiovascular mortality in maintenance hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2007;49(3):417-25.
2007: Masaaki Inaba; Senji Okuno; Yasuro Kumeda; Shinsuke Yamada; Yasuo Imanishi; Tsutomu Tabata; Mikio Okamura; Shigeki Okada; Tomoyuki Yamakawa; Eiji Ishimura; Yoshiki Nishizawa
Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.
Journal of the American Society of Nephrology : JASN 2007;18(3):896-903.
2007: Kaori Shidara; Masaaki Inaba; Senji Okuno; Yasuo Imanishi; Tomoyuki Yamakawa; Eiji Ishimura; Yasuro Kumeda; Yoshiki Nishizawa
Influence of nutritional status on serum large N-truncated PTH, but not PTH(1-84) in hemodialysis patients.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2007;61(2-3):142-7.
2006: Masaaki Inaba; Senji Okuno; Yasuo Imanishi; Shinsuke Yamada; Atsushi Shioi; Tomoyuki Yamakawa; Eiji Ishimura; Yoshiki Nishizawa
Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2006;17(10):1506-13.
2006: Yoko Fujino; Eiji Ishimura; Senji Okuno; Naoki Tsuboniwa; Kiyoshi Maekawa; Tsuyoshi Izumotani; Tomoyuki Yamakawa; Masaaki Inaba; Yoshiki Nishizawa
Annual fat mass change is a significant predictor of mortality in female hemodialysis patients.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2006;60(5):253-7.
2006: Masaaki Inaba; Senji Okuno; Hidenori Chou; Yasuo Imanishi; Misako Ueda; Tomoyuki Yamakawa; Eiji Ishimura; Yoshiki Nishizawa
Positive correlation of serum bio-intact PTH(1-84) but not intact PTH with parathyroid gland size in hemodialysis patients.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2006;60(2):62-5.
2006: Takehisa Kawata; Yasuo Imanishi; Keisuke Kobayashi; Naoyoshi Onoda; Senji Okuno; Yoshiaki Takemoto; Takeshi Komo; Hideki Tahara; Michihito Wada; Nobuo Nagano; Eiji Ishimura; Takami Miki; Tetsuro Ishikawa; Masaaki Inaba; Yoshiki Nishizawa
Direct in vitro evidence of the suppressive effect of cinacalcet HCl on parathyroid hormone secretion in human parathyroid cells with pathologically reduced calcium-sensing receptor levels.
Journal of bone and mineral metabolism 2006;24(4):300-6.
2005: Yoshifumi Maeno; Masaaki Inaba; Senji Okuno; Tomoyuki Yamakawa; Eiji Ishimura; Yoshiki Nishizawa
Serum concentrations of cross-linked N-telopeptides of type I collagen: new marker for bone resorption in hemodialysis patients.
Clinical chemistry 2005;51(12):2312-7.
2005: Takehisa Kawata; Yasuo Imanishi; Keisuke Kobayashi; Naoyoshi Onoda; Yoshiaki Takemoto; Hideki Tahara; Senji Okuno; Eiji Ishimura; Takami Miki; Tetsuro Ishikawa; Masaaki Inaba; Yoshiki Nishizawa
Direct in vitro evidence of extracellular Ca2+-induced amino-terminal truncation of human parathyroid hormone (1-84) by human parathyroid cells.
The Journal of clinical endocrinology and metabolism 2005;90(10):5774-8.
2005: Kaori Shidara; Masaaki Inaba; Yasuro Kumeda; Yasuo Imanishi; Hideki Tahara; Eiji Ishimura; Yoshiki Nishizawa; Tomoyuki Yamakawa; Senji Okuno
[Significance of serum PTH (7-84) as a reliable nutritional marker in hemodialysis patients].
Clinical calcium 2005;15 Suppl 1():102-4; discussion 104-5.
2005: Takehisa Kawata; Yasuo Imanishi; Keisuke Kobayashi; Hideki Tahara; Eiji Ishimura; Masaaki Inaba; Yoshiki Nishizawa; Yoshiaki Takemoto; Naoyoshi Onoda; Senji Okuno; Tetsuro Ishikawa
[Effect of calcium on N-terminal truncation of PTH in human parathyroid cells].
Clinical calcium 2005;15 Suppl 1():98-100; discussion 100-1.
2005: Masaaki Inaba; Yasuo Imanishi; Misako Ueda; Hidenori Cho; Hideki Tahara; Eiji Ishimura; Yoshiki Nishizawa; Tomoyuki Yamakawa; Senji Okuno
[Correlation of serum Bio-intact PTH (1-84) and parathyroid gland size in hemodialysed patients].
Clinical calcium 2005;15 Suppl 1():64-6; discussion 66-7.
2005: Misako Ueda; Masaaki Inaba; Senji Okuno; Yoshifumi Maeno; Eiji Ishimura; Tomoyuki Yamakawa; Yoshiki Nishizawa
Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
Life sciences 2005;77(10):1130-9.
2005: Yoko Fujino; Eiji Ishimura; Senji Okuno; Naoki Tsuboniwa; Kiyoshi Maekawa; Tsuyoshi Izumotani; Tomoyuki Yamakawa; Masaaki Inaba; Yoshiki Nishizawa
C-reactive protein is a significant predictor of decrease in fat mass in hemodialysis patients.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2005;59(5):264-8.
2005: Masaaki Inaba; Senji Okuno; Yasuo Imanishi; Misako Ueda; Tomoyuki Yamakawa; Eiji Ishimura; Yoshiki Nishizawa
Significance of Bio-intact PTH(1-84) assay in hemodialysis patients.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2005;16(5):517-25.
2005: Senji Okuno; Masaaki Inaba; Kayoko Kitatani; Eiji Ishimura; Tomoyuki Yamakawa; Yoshiki Nishizawa
Serum levels of C-terminal telopeptide of type I collagen: a useful new marker of cortical bone loss in hemodialysis patients.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2005;16(5):501-9.
2005: Masaaki Inaba; Senji Okuno; Yasuro Kumeda; Tomoyuki Yamakawa; Eiji Ishimura; Yoshiki Nishizawa
Increased incidence of vertebral fracture in older female hemodialyzed patients with type 2 diabetes mellitus.
Calcified tissue international 2005;76(4):256-60.
2004: Eiji Ishimura; Senji Okuno; Kayoko Kitatani; Kiyoshi Maekawa; Tsuyoshi Izumotani; Tomoyuki Yamakawa; Shuichi Jono; Tetsuo Shoji; Atsushi Shioi; Masaaki Inaba; Shaul G Massry; Yoshiki Nishizawa
C-reactive protein is a significant predictor of vascular calcification of both aorta and hand arteries.
Seminars in nephrology 2004;24(5):408-12.
2004: Yasuo Imanishi; Masaaki Inaba; Kiyoshi Nakatsuka; Kyoko Nagasue; Senji Okuno; Asami Yoshihara; Masakazu Miura; Akimitsu Miyauchi; Keisuke Kobayashi; Takami Miki; Tetsuo Shoji; Eiji Ishimura; Yoshiki Nishizawa
FGF-23 in patients with end-stage renal disease on hemodialysis.
Kidney international 2004;65(5):1943-6.
2003: Senji Okuno; Eiji Ishimura; Kayoko Kitatani; Hidenori Chou; Kyoko Nagasue; Kiyoshi Maekawa; Tsuyoshi Izumotani; Tomoyuki Yamakawa; Yasuo Imanishi; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Relationship between parathyroid gland size and responsiveness to maxacalcitol therapy in patients with secondary hyperparathyroidism.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2003;18(12):2613-21.
2003: Kyoko Nagasue; Masaaki Inaba; Senji Okuno; Kayoko Kitatani; Yasuo Imanishi; Eiji Ishimura; Takami Miki; Masao Kim; Yoshiki Nishizawa
Serum N-terminal midfragment vs. intact osteocalcin immunoradiometric assay as markers for bone turnover and bone loss in hemodialysis patients.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2003;57(2):98-104.
2003: Eiji Ishimura; Senji Okuno; Taro Marukawa; Yoshikazu Katoh; Toshiyuki Hiranaka; Tomoyuki Yamakawa; Hirotoshi Morii; Masao Kim; Naoki Matsumoto; Tetsuo Shoji; Masaaki Inaba; Tatsuya Nakatani; Yoshiki Nishizawa
Body fat mass in hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2003;41(3 Suppl 1):S137-41.
2003: Yoshiki Nishizawa; Tetsuo Shoji; Kiyoshi Maekawa; Kyoko Nagasue; Senji Okuno; Masao Kim; Masanori Emoto; Eiji Ishimura; Tatsuya Nakatani; Takami Miki; Masaaki Inaba
Intima-media thickness of carotid artery predicts cardiovascular mortality in hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2003;41(3 Suppl 1):S76-9.
2002: Eiji Ishimura; Senji Okuno; Kayoko Kitatani; Masao Kim; Tetsuo Shoji; T Nakatani; Masaaki Inaba; Yoshiki Nishizawa
Different risk factors for peripheral vascular calcification between diabetic and non-diabetic haemodialysis patients--importance of glycaemic control.
Diabetologia 2002;45(10):1446-8.
2002: Misako Ueda; Masaaki Inaba; Senji Okuno; Kyoko Nagasue; Kayoko Kitatani; Eiji Ishimura; Motokazu Shimizu; Takami Miki; Masao Kim; Yoshiki Nishizawa
Clinical usefulness of the serum N-terminal propeptide of type I collagen as a marker of bone formation in hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2002;40(4):802-9.
2002: Masaaki Inaba; Kyoko Nagasue; Senji Okuno; Misako Ueda; Yasuro Kumeda; Yasuo Imanishi; Tetsuo Shoji; Eiji Ishimura; Tomohiro Ohta; Tatsuya Nakatani; Masao Kim; Yoshiki Nishizawa
Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitus.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2002;39(6):1261-9.
2002: Hideki Ueda; Eiji Isimura; Senji Okuno; Kiyoshi Maekawa; Tsuyoshi Izumotani; Masao Kim; Naoki Matsumoto; Shinya Fukumoto; Yasuo Imanishi; Masanori Emoto; Tetsuo Shoji; Hideki Wanibuchi; Masaaki Inaba; Yoshiki Nishizawa
[Sibling cases of nephritis resembling membranoproliferative glomerulonephritis].
Nihon Jinzo Gakkai shi 2002;44(4):420-6.
2001: Senji Okuno; Eiji Ishimura; Masao Kim; Tsuyoshi Izumotani; T Otoshi; Kiyoshi Maekawa; Tomoyuki Yamakawa; Hirotoshi Morii; Masaaki Inaba; Yoshiki Nishizawa
Changes in body fat mass in male hemodialysis patients: a comparison between diabetics and nondiabetics.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2001;38(4 Suppl 1):S208-11.
2001: Masaaki Inaba; Senji Okuno; Kyoko Nagasue; T Otoshi; Y Kurioka; Kiyoshi Maekawa; Yasuro Kumeda; Yasuo Imanishi; Eiji Ishimura; T Ohta; Hirotoshi Morii; Masao Kim; Yoshiki Nishizawa
Impaired secretion of parathyroid hormone is coherent to diabetic hemodialyzed patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2001;38(4 Suppl 1):S139-42.
2001: Tsuyoshi Izumotani; Eiji Ishimura; T Yamamoto; T Otoshi; Senji Okuno; Masaaki Inaba; Masao Kim; Yoshiki Nishizawa
Correlation between peritoneal mesothelial cell cytology and peritoneal histopathology with respect to prognosis in patients on continuous ambulatory peritoneal dialysis.
Nephron 2001;89(1):43-9.
2001: Eiji Ishimura; Senji Okuno; Masao Kim; T Yamamoto; Tsuyoshi Izumotani; T Otoshi; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Increasing body fat mass in the first year of hemodialysis.
Journal of the American Society of Nephrology : JASN 2001;12(9):1921-6.
1999: Eiji Ishimura; Yoshiki Nishizawa; Masaaki Inaba; N Matsumoto; Masanori Emoto; Takahiko Kawagishi; S Shoji; Senji Okuno; M Kim; Takami Miki; Hirotoshi Morii
Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure.
Kidney international 1999;55(3):1019-27.